Evoke Pharma (EVOK) Misses Q1 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
• PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance